JMP Securities Reiterates Market Outperform on Crinetics Pharmaceuticals, Maintains $80 Price Target
JMP Securities Reiterates Market Outperform on Crinetics Pharmaceuticals, Maintains $80 Price Target
JMP證券重申Crinetics Pharmicals的市場表現跑贏大盤，維持80美元的目標股價
JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and maintains $80 price target.
JMP Securities分析師喬納森·沃勒本重申了Crinetics Pharmicals（納斯達克股票代碼：CRNX）的市場跑贏大盤，並維持80美元的目標股價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。